NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Lexaria Bioscience Corp. Common Stock Share Price Chart

O H L

Lexaria Bioscience Corp. Common Stock Performance Overview

Days Range
$2.91Low
$3.94High

Markets Today

Previous Close$3.29
Open$3.36
Volume164,311
Day's Range$2.91 - $3.94
52W Range$2.80 - $23.25
Market Cap$6.52 M

Historical Performance

1M Returns-71.44
3M Returns-59.40
6M Returns-70.56
1Y Returns-82.02
5Y Returns-96.53
10Y ReturnsNA

Lexaria Bioscience Corp. Common Stock Fundamentals

Market Cap$6.52 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$705.92 K
ROE TTM-2.16
EPS TTM$-5.28
Quarterly Earnings Growth YOYN/A
PB Ratio1.08
EBITDA$-11.79 M
Profit Margin-1686.00
Market Cap$6.52 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$705.92 K
ROE TTM-2.16
EPS TTM$-5.28
Quarterly Earnings Growth YOYN/A
PB Ratio1.08
EBITDA$-11.79 M
Profit Margin-1686.00

Lexaria Bioscience Corp. Common Stock Profit & Loss

Feb 2025May 2025Aug 2025Nov 2025Feb 2026May 2026
Total Revenue +$174.00 K$174.00 K$174.00 K$0$20.00 K$0
Gross Profit +$174.00 K$174.00 K$174.00 K$0$20.00 K$0
Operating Income -$2.75 M-$3.75 M-$2.69 M-$1.57 M-$1.45 M-$1.99 M
EBITDA -$2.75 M-$3.72 M-$2.67 M-$1.56 M-$1.43 M-$1.97 M
Interest Expense $0$0$0$0$0$0
Depreciation $2.28 K$30.95 K$21.40 K$16.87 K$19.10 K$19.21 K
Income Before Tax -$2.72 M-$3.79 M-$2.70 M-$1.60 M-$1.45 M-$1.99 M
Income Tax Expense $0$0$0$1.79 K$2.60 K$14
Net Income +-$2.72 M-$3.79 M-$2.70 M-$1.60 M-$1.45 M-$1.99 M
Net Profit Margin -1561.48%-2178.51%-1550.13%--7263.66%-

Lexaria Bioscience Corp. Common Stock Financials Balance Sheet In USD

Feb 2025May 2025Aug 2025Nov 2025Feb 2026May 2026
Share Capital $17.56 K$19.56 K$19.56 K$22.23 K$24.89 K$24.79 K
Reserve & Surplus -$57.09 M-$60.85 M-$63.53 M-$65.13 M-$66.56 M-$68.54 M
Non-Current Liabilities $94.39 K$86.71 K$78.90 K$70.82 K$62.33 K$53.68 K
Current Liabilities $1.82 M$1.49 M$1.49 M$1.46 M$214.67 K$383.41 K
Total Liabilities $1.92 M$1.57 M$1.57 M$1.53 M$277.00 K$437.09 K
Fixed Assets $768.07 K$756.56 K$535.95 K$524.18 K$560.99 K$568.03 K
Current Assets $7.72 M$5.81 M$3.47 M$5.36 M$5.77 M$4.06 M
Total Assets $8.68 M$6.74 M$4.18 M$6.05 M$6.49 M$4.78 M

Lexaria Bioscience Corp. Common Stock Cash Flow

Feb 2025May 2025Aug 2025Nov 2025Feb 2026May 2026
Net Income -$2.72 M-$3.79 M-$2.70 M-$1.60 M-$1.45 M-$1.99 M
Operating Cash Flow -$1.50 M-$3.58 M-$2.64 M-$984.10 K-$2.16 M-$1.64 M
Investing Cash Flow -$27.89 K-$19.44 K-$157.88 K-$5.10 K-$53.91 K-$27.09 K
Financing Cash Flow $11.72 K$1.69 M$0$3.47 M$3.04 M$0
Change in Cash -$1.61 M-$1.88 M-$2.79 M$2.48 M$846.91 K-$1.65 M

Lexaria Bioscience Corp. Common Stock Return Calculator

The Lexaria Bioscience Corp. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$346
Invested Amount$10,000
Est. Returns$-9,654
Invest in USA Stock Today

About Lexaria Bioscience Corp. Common Stock

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

FAQs

Lexaria Bioscience Corp. Common Stock (LEXX) share price as of September 18, 2026 is $3.28. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Lexaria Bioscience Corp. Common Stock (LEXX) Share by opening an international trading account with Angel One.
Purchasing Lexaria Bioscience Corp. Common Stock (LEXX) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Lexaria Bioscience Corp. Common Stock (LEXX) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Lexaria Bioscience Corp. Common Stock (LEXX) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Lexaria Bioscience Corp. Common Stock on September 18, 2026, is $6.52 M.
Lexaria Bioscience Corp. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Lexaria Bioscience Corp. Common Stock (LEXX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91